Tregs can modify immune responses by suppressing effector T cell responses or secreting the cytokines IL-10 and TGF-β to create immunological tolerance, even though IL-10 may be the most promising of the anti-inflammatory interleukins being researched to prevent type 1 diabetes [32]. This evidence concerns the gene TGFB1 and type 1 diabetes mellitus.